{
    "nctId": "NCT05466786",
    "briefTitle": "Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer",
    "officialTitle": "Landscape Ofhomologous Recombination-related (HRR) Genes Mutations and HRD, and Correlation With Survival in HER2-lowbreast Cance",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer, HER2-low Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 335,
    "primaryOutcomeMeasure": "1.To assess the distribution characteristics of mHRR/HRD in breast cancer with low HRE2 expression in Chinese population",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. female patients who have pathologically documented breast cancer that: Has a history of HER2-low expression, defined as IHC 2+/ISH- or IHC 1+ (ISH- or untested) with a validated assay ASCO/CAP guidelines in the metastatic setting\n2. Femalepatients must be at least 18 years of age\n3. ECOG Performance Status of 0 or 1\n4. patients with operable primary breast cancer who underwent radical surgery and No patients received preoperative neoadjuvant therapy.\n5. No distant metastasis occurred\n6. Patient must have adequate tumor andbloodsample for biomarker assessment\n\nExclusion Criteria:\n\n1. recurrent or advanced metastatic breast cancer\n2. Bilateral breast cancer (including multifocal breast cancer. All histological lesions were HER2 1+ or 2+, not detected by FISH amplification and HR positive according to ASCO guidelines)\n3. Other malignant tumors within 5?years\n4. Clinical diagnosis and treatment information is incomplete",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}